Get notified when NUS files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Goodwill Impairment (new) — A $78.9 million goodwill impairment was recorded in Q2 2026, signaling the manufacturing reporting unit's fair value fell below carrying value.
- Asset Impairment (new) — A $1.8 million impairment charge was recorded in Q1 2026 related to the wind-down of the BeautyBio business.
Nu Skin swings to Q3 loss on $78.9M goodwill impairment and $167.5M tax charge
Filed November 6, 2026 · Period ending September 30, 2026 · Compared to 10-Q Nov 7, 2025 · ~1 min read
Key Changes
-
high
Revenue fell 14.6% to $311.0M in Q3 2026, and EPS swung to a loss of $(0.02) from $0.34 a year earlier.
MD&A verify on EDGAR → -
high
Cash flow from operations turned negative in the first nine months of 2026, with a net outflow of $1.4M versus $63.7M inflow a year ago.
MD&A verify on EDGAR → -
medium
The company refinanced its credit agreement, cutting the term loan from $400M to $175M and the revolver from $500M to $75M.
MD&A verify on EDGAR →
1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (OWL 10-Q) is open in full — no account needed.
Partner
Trade NUS commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Nov 9, 2026 · How we verify